Inspire Medical Systems (INSP) Projected to Post Earnings on Monday

Inspire Medical Systems (NYSE:INSP - Get Free Report) is expected to be releasing its earnings data after the market closes on Monday, February 10th. Analysts expect Inspire Medical Systems to post earnings of $0.74 per share and revenue of $239.76 million for the quarter. Parties that wish to listen to the company's conference call can do so using this link.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last announced its earnings results on Monday, November 4th. The company reported $0.60 EPS for the quarter, topping the consensus estimate of $0.06 by $0.54. Inspire Medical Systems had a net margin of 4.37% and a return on equity of 5.30%. The business had revenue of $203.20 million during the quarter, compared to analysts' expectations of $197.59 million. During the same quarter in the prior year, the company posted ($0.29) earnings per share. The firm's revenue was up 32.6% on a year-over-year basis. On average, analysts expect Inspire Medical Systems to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Inspire Medical Systems Price Performance

INSP stock traded down $10.86 during midday trading on Thursday, hitting $181.14. The company's stock had a trading volume of 464,567 shares, compared to its average volume of 590,982. The company's fifty day moving average price is $190.19 and its 200 day moving average price is $189.74. Inspire Medical Systems has a twelve month low of $123.00 and a twelve month high of $257.40. The stock has a market capitalization of $5.43 billion, a P/E ratio of 169.29 and a beta of 1.32.

Wall Street Analysts Forecast Growth

INSP has been the subject of several analyst reports. Stifel Nicolaus decreased their target price on shares of Inspire Medical Systems from $200.00 to $190.00 and set a "hold" rating for the company in a research note on Tuesday, January 21st. Bank of America raised Inspire Medical Systems from a "neutral" rating to a "buy" rating and lifted their target price for the stock from $220.00 to $255.00 in a report on Wednesday, November 20th. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $260.00 price objective on shares of Inspire Medical Systems in a report on Tuesday, November 5th. Piper Sandler reiterated an "overweight" rating and set a $260.00 price target (up previously from $255.00) on shares of Inspire Medical Systems in a research report on Tuesday, November 5th. Finally, Wells Fargo & Company lifted their target price on Inspire Medical Systems from $187.00 to $198.00 and gave the company an "equal weight" rating in a research report on Tuesday, November 5th. Three investment analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $231.45.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.